Literature DB >> 1866745

Immunohematologic characteristics of infection-associated cerebral infarction.

S F Ameriso1, V L Wong, F P Quismorio, M Fisher.   

Abstract

We evaluated 50 consecutive patients with acute ischemic stroke to assess the prevalence of systemic infection preceding the neurological event. We analyzed the immunohematologic characteristics of patients with and without signs and/or symptoms of a preceding infectious process. Patients were examined less than or equal to 7 days after cerebral infarction and evaluated for fibrinogen, anticardiolipin antibodies, fibrin D-dimer (a fragment of cross-linked fibrin), plasminogen activator inhibitor-1, and protein S. Of the 50 patients, 17 had symptoms of infection beginning less than or equal to 1 month before the stroke (11 had upper respiratory tract infections, three urinary tract infections, two subacute bacterial endocarditis, and one pneumonia). Compared with patients without infection, patients with infection had significant increases in fibrin D-dimer concentration (5.3 +/- 1.1 versus 4.7 +/- 0.9 log-transformed ng/ml, p less than 0.05) and cardiolipin immunoreactivity, IgG isotype (1.8 +/- 1.3 versus 1.1 +/- 0.9 log-transformed phospholipid units, p less than 0.04), and, when studied less than or equal to 2 days after the stroke, increased fibrinogen levels (459 +/- 126 versus 360 +/- 94 mg/dl, p less than 0.05). In conclusion, infection-associated cerebral infarction is common and is associated with substantial immunohematologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866745     DOI: 10.1161/01.str.22.8.1004

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Technical refinements and drawbacks of a surface cooling technique for the treatment of severe acute ischemic stroke.

Authors:  Alex Abou-Chebl; Michael A DeGeorgia; John C Andrefsky; Derk W Krieger
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke.

Authors:  P Belani; J Schefflein; S Kihira; B Rigney; B N Delman; K Mahmoudi; J Mocco; S Majidi; J Yeckley; A Aggarwal; D Lefton; A H Doshi
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

Review 3.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

Review 4.  Stroke in children.

Authors:  Sheffali Gulati; Veena Kalra
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

5.  The effects of ceftriaxone on skill learning and motor functional outcome after ischemic cortical damage in rats.

Authors:  Soo Young Kim; Theresa A Jones
Journal:  Restor Neurol Neurosci       Date:  2013       Impact factor: 2.406

6.  Exposure to the US Stroke Buckle as a risk factor for cerebrovascular mortality.

Authors:  Ilan Shrira; Nicholas Christenfeld; George Howard
Journal:  Neuroepidemiology       Date:  2008-04-25       Impact factor: 3.282

Review 7.  Childhood infections and trauma as risk factors for stroke.

Authors:  Elena Moraitis; Vijeya Ganesan
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

8.  Clinico-etiological profile of childhood stroke in a Tertiary Care Hospital in Eastern India.

Authors:  Chaitali Patra; Shatanik Sarkar; Debasree Guha; Malay K Dasgupta
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

9.  Newly recognized cerebral infarctions on postmortem imaging: a report of three cases with systemic infectious disease.

Authors:  Sakon Noriki; Kazuyuki Kinoshita; Kunihiro Inai; Toyohiko Sakai; Hirohiko Kimura; Takahiro Yamauchi; Masayuki Iwano; Hironobu Naiki
Journal:  BMC Med Imaging       Date:  2017-01-10       Impact factor: 1.930

10.  Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic.

Authors:  Shingo Kihira; Javin Schefflein; Michael Chung; Keon Mahmoudi; Brian Rigney; Bradley N Delman; J Mocco; Amish Doshi; Puneet Belani
Journal:  J Neurointerv Surg       Date:  2020-05-19       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.